Related Experiment Videos
Current strategies for management of hypertensive renal disease
Insights
Controlling hypertension is key to reducing end-stage renal disease. Lowering blood pressure to 130/85 mm Hg, or 120/75 mm Hg for African Americans, and using ACE inhibitors can protect kidneys.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Management
Background:
- Hypertensive end-stage renal disease (ESRD) incidence is rising.
- Effective hypertension control is crucial for preventing renal decline.
- Reversible causes of renal insufficiency in hypertensive patients require investigation.
Purpose of the Study:
- To outline strategies for reducing the incidence of hypertensive ESRD.
- To emphasize the importance of blood pressure control in renal protection.
- To highlight specific blood pressure targets and therapeutic agents.
Main Methods:
- Review of current guidelines and evidence on hypertension and renal disease.
- Analysis of blood pressure targets for general hypertensive patients and specific populations.
- Discussion of the role of antihypertensive medications, particularly ACE inhibitors.
Main Results:
- Blood pressure should be managed to 130/85 mm Hg.
- A target of 120/75 mm Hg may benefit African Americans with hypertensive renal failure.
- Antihypertensive regimens effectively slow renal failure progression.
Conclusions:
- Aggressive blood pressure control is essential for preventing hypertensive ESRD.
- Targeted blood pressure reduction and specific drug classes like ACE inhibitors offer renoprotection.
- Identifying and treating reversible causes of renal insufficiency is critical.
Abstract:
The incidence of hypertensive end-stage renal disease continues to increase annually. To reduce this incidence, it is necessary to control systolic and diastolic hypertension. Reversible causes should always be sought in any hypertensive patient who develops renal insufficiency. Blood pressure should be reduced to 130/85 mm Hg, and in African Americans with hypertensive renal failure, reducing the blood pressure to 120/75 mm Hg may be beneficial. Any antihypertensive treatment regimen that effectively lowers blood pressure will help slow progressive renal failure. Whenever possible, an angiotensin-converting enzyme inhibitor should be part of the treatment, since these drugs have been shown to be renoprotective beyond their antihypertensive effect in certain renal disease categories.